US EditionOzempic-like drug significantly reduces frequency of chronic migraines in pilot study
Summary by Medical Xpress
2 Articles
2 Articles
All
Left
Center
1
Right
Ozempic-like drug significantly reduces frequency of chronic migraines in pilot study
Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment options, some migraine sufferers cannot find relief in available drugs. Others experience side effects that prevent the use of certain available migraine medications.
GLP-1 medicines can have a new power: the relaxation of migraines. In a small preliminary study, a GLP-1 drug has almost halved the number of days people spent with migraine in a given month. The results, presented on 21 June at the Congress of the European Academy of Neurology in [...]
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
